Category Archives : News

Home  >>  News

BioMed X and Merck extend research collaboration in oncology

On May 8, 2018, Posted by , In News, By ,, , With Comments Off on BioMed X and Merck extend research collaboration in oncology

BioMed X announced the start of a new research project in collaboration with Merck at its Innovation Center in Heidelberg. The new team will focus on the identification of novel approaches to exploit tumor-specific RNA splicing alterations for targeted cancer therapy.     Dr. Jan Mauer, who joined the BioMed X…

EMBL – CRISPR: from clipping scissors to word processor

On May 8, 2018, Posted by , In News, By ,, , With Comments Off on EMBL – CRISPR: from clipping scissors to word processor

Barcodes are used in a new way in the MAGESTIC platform, adding a new level of precision to CRISPR gene editing. Credit: Kelly Irvine/NIST Using the gene-editing tool CRISPR to snip at DNA is often akin to using scissors to edit a newspaper article. You can cut out words, but it’s…

Affimed Introduces ROCK™ Platform for Tailored Immune Cell Engagers

On May 4, 2018, Posted by , In News, By , , With Comments Off on Affimed Introduces ROCK™ Platform for Tailored Immune Cell Engagers

Affimed N.V., a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced the official launch of its Redirected Optimized Cell Killing (ROCK™) platform. Based on the company’s long-standing expertise in drug development and protein engineering, the ROCK™ platform enables the generation of both NK…

EMBL: Protein stability and solubility during cell cycle

On May 3, 2018, Posted by , In News, By , , With Comments Off on EMBL: Protein stability and solubility during cell cycle

  Dividing cell colored in a heat gradient, highlighting the variation in proteins’ thermal stability within and between different cell cycle stages. IMAGE: Aleksandra Krolik / EMBL EMBL scientists uncover large solubility and thermal stability changes of proteins during cell cycle The cell cycle is a highly dynamic process that…

University Hospital HD / Sumaya Biotech: New vaccine candidate against malaria successfully tested in first clinical trial

On May 2, 2018, Posted by , In News, By , , With Comments Off on University Hospital HD / Sumaya Biotech: New vaccine candidate against malaria successfully tested in first clinical trial

A novel vaccine candidate against the causative agent of malaria tropica, the most severe form of human malaria, has now been successfully tested for safety, tolerability and immunogenicity (ability to produce antibodies). Experts of the Department of Clinical Pharmacology and Pharmacoepidemiology of the University Hospital Heidelberg (directed by Prof. Dr….

European QuickFire Challenge for startups – Apply to receive €100,000 + @JLABS residency

On April 25, 2018, Posted by , In News, By , With Comments Off on European QuickFire Challenge for startups – Apply to receive €100,000 + @JLABS residency

European Innovation QuickFire Challenge! Innovators with ideas, technologies, and solutions that improve human healthcare and impact the European ecosystem can now apply for up to €100,000 in grants and one year of residency at an available JLABS location, including access to the global JLABS community. Encouraged applications from companies working…

DKFZ/Heidelberg University: ERC Advanced Grants for Hellmut Augustin and Christof Niehrs

On April 23, 2018, Posted by , In News, By ,, , With Comments Off on DKFZ/Heidelberg University: ERC Advanced Grants for Hellmut Augustin and Christof Niehrs

The European Research Council ERC’s Advanced Grants promote visionary projects of fundamental research. This year, Hellmut Augustin (University of Heidelberg and DKFZ) and Christof Niehrs (University of Mainz and DKFZ) received the prestigious funding. Hellmut Augustin © DKFZ The European Research Council, set up in 2007, promotes fundamental research in…

EMBL: PDX Finder – Free global portal for cancer models

On April 9, 2018, Posted by , In News, By , With Comments Off on EMBL: PDX Finder – Free global portal for cancer models

First global online catalogue of PDX models facilitates collaboration and helps cancer researchers save valuable time The European Bioinformatics Institute (EMBL-EBI) and The Jackson Laboratory (JAX) have jointly developed the first open cancer research portal for Patient Derived Xenograft (PDX) models. The freely available PDX Finder is hosted by EMBL-EBI…

New member: Welcome to PEKKIP Oncology Alliance in our cluster

On April 4, 2018, Posted by , In News, By , With Comments Off on New member: Welcome to PEKKIP Oncology Alliance in our cluster

We are happy to welcome in our cluster PEKKIP Oncology Alliance.   “Fighting cancer needs genius and expertise – but prior to all it needs cooperation.” Ahmet Sami Pekkip – CEO PEKKIP Oncology Alliance have an excellent network of internationally renowned key opinion leaders at hand. They use this pool…

Remote Learning: new Master in Biotechnology (M.Sc.) starts in the winter semester 2018

On April 4, 2018, Posted by , In News, By , With Comments Off on Remote Learning: new Master in Biotechnology (M.Sc.) starts in the winter semester 2018

Esslingen University of Applied Sciences together with the scientific publisher Springer, established a new remote learning Master in Biotechnology. This Master is the perfect solution for professionals who want to continue their education, without leaving their job. After 5,5 semesters, the students will receive a Master of Science (M.Sc.) in…